FEBS Letters
Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors
FEBS Letters, Volume 596, Issue 24, Page 3107-3123, December 2022.
FEBS Letters
The immunoreceptor SLAMF8 promotes the differentiation of follicular dendritic cell‐dependent monocytic cells with B cell‐activating ability
FEBS Letters, Volume 596, Issue 20, Page 2659-2667, October 2022.
FEBS Letters
Umbilical cord mesenchymal stem cell‐derived exosomes alleviate collagen‐induced arthritis by balancing the population of Th17 and regulatory T cells
FEBS Letters, Volume 596, Issue 20, Page 2668-2677, October 2022.
FEBS Letters
cAMP‐induced decrease in cell‐surface laminin receptor and cellular prion protein attenuates amyloid‐β uptake and amyloid‐β‐induced neuronal cell death
FEBS Letters, Volume 596, Issue 22, Page 2914-2927, November 2022.
FEBS Letters
The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT‐20 cells in vitro
FEBS Letters, Volume 596, Issue 21, Page 2781-2794, November 2022.
FEBS Letters
Loss of function of an Arabidopsis homologue of JMJD6 suppresses the dwarf phenotype of acl5, a mutant defective in thermospermine biosynthesis
FEBS Letters, Volume 596, Issue 23, Page 3005-3014, December 2022.
FEBS Letters
Heteromerization between α1B‐adrenoceptor and chemokine (C‐C motif) receptor 2 biases α1B‐adrenoceptor signaling: Implications for vascular function
FEBS Letters, Volume 596, Issue 20, Page 2706-2716, October 2022.
FEBS Letters
Electrogenic reaction step and phospholipid translocation pathway of the mammalian P4‐ATPase ATP8A2
FEBS Letters, Volume 597, Issue 4, Page 495-503, February 2023.
FEBS Letters
Heparin promotes rapid fibrillation of the basic parathyroid hormone at physiological pH
FEBS Letters, Volume 596, Issue 22, Page 2928-2939, November 2022.